liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
Spanish Natl Canc Res Ctr, Human Genet Grp, Madrid, Spain.
Spanish Natl Canc Res Ctr, Genet and Mol Epidemiol Grp, Madrid, Spain.
Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain.
Fdn IRCCS Ist Nazl Tumori, Milan, Italy.
Vise andre og tillknytning
2009 (engelsk)Inngår i: British Journal of Cancer, ISSN 0007-0920, E-ISSN 1532-1827, Vol. 101, nr 12, s. 2048-2054Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND: In this study we aimed to evaluate the role of a SNP in intron I of the ERCC4 gene (rs744154), previously reported to be associated with a reduced risk of breast cancer in the general population, as a breast cancer risk modifier in BRCA1 and BRCA2 mutation carriers. METHODS: We have genotyped rs744154 in 9408 BRCA1 and 5632 BRCA2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and assessed its association with breast cancer risk using a retrospective weighted cohort approach. RESULTS: We found no evidence of association with breast cancer risk for BRCA1 (per-allele HR: 0.98, 95% CI: 0.93-1.04, P = 0.5) or BRCA2 (per-allele HR: 0.97, 95% CI: 0.89-1.06, P = 0.5) mutation carriers. CONCLUSION: This SNP is not a significant modifier of breast cancer risk for mutation carriers, though weak associations cannot be ruled out.

sted, utgiver, år, opplag, sider
2009. Vol. 101, nr 12, s. 2048-2054
Emneord [en]
BRCA1; BRCA2; ERCC4; breast cancer
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-52912DOI: 10.1038/sj.bjc.6605416OAI: oai:DiVA.org:liu-52912DiVA, id: diva2:285720
Tilgjengelig fra: 2010-01-12 Laget: 2010-01-12 Sist oppdatert: 2017-12-12

Open Access i DiVA

fulltext(366 kB)268 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 366 kBChecksum SHA-512
ac27795f43ad886854570ddb83aba57dfb31242e20c140c9a989f8c5fdaafe309fd8ca7058f9fea5997aac85fb54acd27616add27385daebb75f6220d49705a7
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekst

Personposter BETA

Stenmark Askmalm, Marie

Søk i DiVA

Av forfatter/redaktør
Stenmark Askmalm, Marie
Av organisasjonen
I samme tidsskrift
British Journal of Cancer

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 268 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 171 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf